Cargando…
Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines
BACKGROUND: Actinobacillus pleuropneumoniae is the causative agent of porcine pleuropneumonia and represents a major burden to the livestock industry. Virulence can largely be attributed to the secretion of a series of haemolytic toxins, which are highly immunogenic. A. pleuropneumoniae also encodes...
Autores principales: | Passmore, Ian J., Andrejeva, Anna, Wren, Brendan W., Cuccui, Jon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318927/ https://www.ncbi.nlm.nih.gov/pubmed/30606265 http://dx.doi.org/10.1186/s12917-018-1751-2 |
Ejemplares similares
-
The N-linking glycosylation system from Actinobacillus pleuropneumoniae is required for adhesion and has potential use in glycoengineering
por: Cuccui, Jon, et al.
Publicado: (2017) -
Development of Actinobacillus pleuropneumoniae ApxI, ApxII, and ApxIII-specific ELISA methods for evaluation of vaccine efficiency
por: Jung, Myunghwan, et al.
Publicado: (2019) -
Enhancement of Apx Toxin Production in Actinobacillus pleuropneumoniae Serotypes 1, 2, and 5 by Optimizing Culture Conditions
por: Dao, Hoai Thu, et al.
Publicado: (2020) -
Recent advances in the production of recombinant glycoconjugate vaccines
por: Kay, Emily, et al.
Publicado: (2019) -
Probing of Actinobacillus pleuropneumoniae ApxIIIA toxin-dependent cytotoxicity towards mammalian peripheral blood mononucleated cells
por: Vanden Bergh, Philippe GAC, et al.
Publicado: (2008)